Related references
Note: Only part of the references are listed.Randomized, Vitamin E-Controlled Trial of Bicyclol Plus Metformin in Non-Alcoholic Fatty Liver Disease Patients with Impaired Fasting Glucose
Ying Han et al.
CLINICAL DRUG INVESTIGATION (2014)
Metformin accumulation: Lactic acidosis and high plasmatic metformin levels in a retrospective case series of 66 patients on chronic therapy
S. Vecchio et al.
CLINICAL TOXICOLOGY (2014)
2013 ESC/EASD guidelines on the management of diabetes and cardiovascular disease: Established knowledge and evidence gaps
Francesco Paneni
DIABETES & VASCULAR DISEASE RESEARCH (2014)
AMP-activated protein kinase: a key regulator of energy balance with many roles in human disease
D. Grahame Hardie
JOURNAL OF INTERNAL MEDICINE (2014)
Berberine and Its Metabolites: Relationship between Physicochemical Properties and Plasma Levels after Administration to Human Subjects
Silvia Spinozzi et al.
JOURNAL OF NATURAL PRODUCTS (2014)
Metformin inhibits hepatitis B virus protein production and replication in human hepatoma cells
Y. -H. Xun et al.
JOURNAL OF VIRAL HEPATITIS (2014)
Metformin Ameliorates Hepatic Steatosis and Inflammation without Altering Adipose Phenotype in Diet-Induced Obesity
Shih-Lung Woo et al.
PLOS ONE (2014)
Metformin and Berberine Prevent Olanzapine-Induced Weight Gain in Rats
Yueshan Hu et al.
PLOS ONE (2014)
Acarbose: an alternative to metformin for first-line treatment in type 2 diabetes?
Ronald C. W. Ma
LANCET DIABETES & ENDOCRINOLOGY (2014)
India suspends pioglitazone: Is it justified?
S. M. Sadikot et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2014)
Safety and Efficacy of Metformin in Patients With Type 2 Diabetes Mellitus and Chronic Hepatitis C
Kira Harris et al.
ANNALS OF PHARMACOTHERAPY (2013)
Effects of metformin on markers of oxidative stress and antioxidant reserve in patients with newly diagnosed type 2 diabetes: A randomized clinical trial
Alireza Esteghamati et al.
CLINICAL NUTRITION (2013)
The Future of Thiazolidinedione Therapy in the Management of Type 2 Diabetes Mellitus
Hanford Yau et al.
CURRENT DIABETES REPORTS (2013)
Pharmacogenetic Variation and Metformin Response
Suning Chen et al.
CURRENT DRUG METABOLISM (2013)
Molecular mechanism of action of metformin: old or new insights?
Graham Rena et al.
DIABETOLOGIA (2013)
Alteration of the intestinal barrier and GLP2 secretion in Berberine-treated type 2 diabetic rats
C. Y. Shan et al.
JOURNAL OF ENDOCRINOLOGY (2013)
Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP
Russell A. Miller et al.
NATURE (2013)
Metformin trims fats to restore insulin sensitivity
Reuben J. Shaw
NATURE MEDICINE (2013)
Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: A systematic review
Maria-Elena Lautatzis et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2013)
Berberine improves insulin resistance in cardiomyocytes via activation of 5′-adenosine monophosphate-activated protein kinase
Wenguang Chang et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2013)
Metformin and cancer: from the old medicine cabinet to pharmacological pitfalls and prospects
Arian Emami Riedmaier et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
Metformin improves healthspan and lifespan in mice
Alejandro Martin-Montalvo et al.
NATURE COMMUNICATIONS (2013)
Metformin: an old but still the best treatment for type 2 diabetes
Lilian Beatriz Aguayo Rojas et al.
DIABETOLOGY & METABOLIC SYNDROME (2013)
Pioglitazone-Do we really need it to manage type 2 diabetes?
Binayak Sinha et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2013)
Metformin-induced mixed hepatocellular and cholestatic hepatic injury: case report and literature review
Tarek Saadi et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2013)
A novel inverse relationship between metformin-triggered AMPK-SIRT1 signaling and p53 protein abundance in high glucose-exposed HepG2 cells
Lauren E. Nelson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2012)
Insulin secretagogues were associated with increased mortality compared with metformin in type 2 diabetes
Gabriela Prutsky et al.
ANNALS OF INTERNAL MEDICINE (2012)
Berberine: New perspectives for old remedies
Micol Tillhon et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Metformin affects the circadian clock and metabolic rhythms in a tissue-specific manner
Maayan Barnea et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
In vitro and in vivo anti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma
Qingqiong Luo et al.
BMC CANCER (2012)
Metformin Prevents Liver Tumorigenesis by Inhibiting Pathways Driving Hepatic Lipogenesis
Kavita Bhalla et al.
CANCER PREVENTION RESEARCH (2012)
Relation between augmentation index and adiponectin during one-year metformin treatment for nonalcoholic steatohepatosis: effects beyond glucose lowering?
Marina Shargorodsky et al.
CARDIOVASCULAR DIABETOLOGY (2012)
Cellular and molecular mechanisms of metformin: an overview
Benoit Viollet et al.
CLINICAL SCIENCE (2012)
Metformin-Induced Hepatotoxicity
Francisco Miralles-Linares et al.
DIABETES CARE (2012)
Long-Term Safety, Tolerability, and Weight Loss Associated With Metformin in the Diabetes Prevention Program Outcomes Study
George A. Bray et al.
DIABETES CARE (2012)
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
S. E. Inzucchi et al.
DIABETOLOGIA (2012)
Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials
G. Musso et al.
DIABETOLOGIA (2012)
Berberine in the Treatment of Type 2 Diabetes Mellitus: A Systemic Review and Meta-Analysis
Hui Dong et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2012)
The Role of Metformin in the Management of NAFLD
Angela Mazza et al.
EXPERIMENTAL DIABETES RESEARCH (2012)
Thiazolidinedione safety
Jacqueline Kung et al.
EXPERT OPINION ON DRUG SAFETY (2012)
Nonalcoholic fatty liver disease (NAFLD): Is it really a serious condition?
Julia Wattacheril et al.
HEPATOLOGY (2012)
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
Naga Chalasani et al.
HEPATOLOGY (2012)
Targeted Overexpression of Inducible 6-Phosphofructo-2-kinase in Adipose Tissue Increases Fat Deposition but Protects against Diet-induced Insulin Resistance and Inflammatory Responses
Yuqing Huo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Palmitoleate Induces Hepatic Steatosis but Suppresses Liver Inflammatory Response in Mice
Xin Guo et al.
PLOS ONE (2012)
Metformin Prevents and Reverses Inflammation in a Non-Diabetic Mouse Model of Nonalcoholic Steatohepatitis
Yuki Kita et al.
PLOS ONE (2012)
Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register
Nils Ekstrom et al.
BMJ OPEN (2012)
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
G. Vernon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Restoration of autophagy by puerarin in ethanol-treated hepatocytes via the activation of AMP-activated protein kinase
Byung-Kyu Noh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant Mice
Yu Li et al.
CELL METABOLISM (2011)
Clinical Pharmacokinetics of Metformin
Garry G. Graham et al.
CLINICAL PHARMACOKINETICS (2011)
Metformin opposes impaired AMPK and SIRT1 function and deleterious changes in core clock protein expression in white adipose tissue of genetically-obese db/db mice
P. W. Caton et al.
DIABETES OBESITY & METABOLISM (2011)
Metformin Activates AMP Kinase through Inhibition of AMP Deaminase
Jiangyong Ouyang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Regulation of hepatic metabolism by AMPK
Marc Foretz et al.
JOURNAL OF HEPATOLOGY (2011)
AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespan
Antero Salminen et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic Gluconeogenesis
Xuan Xia et al.
PLOS ONE (2011)
Meta-analysis: insulin sensitizers for the treatment of non-alcoholic steatohepatitis
M. O. Rakoski et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Metformin reverses hexokinase and 6-phosphofructo-1-kinase inhibition in skeletal muscle, liver and adipose tissues from streptozotocin-induced diabetic mouse
Daniel Da Silva et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2010)
Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis
Andrea DeCensi et al.
CANCER PREVENTION RESEARCH (2010)
Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression
Eek Joong Park et al.
CELL (2010)
Thiazolidinedione Drugs and Cardiovascular Risks A Science Advisory From the American Heart Association and American College of Cardiology Foundation
Sanjay Kaul et al.
CIRCULATION (2010)
Metformin selectively attenuates mitochondrial H2O2 emission without affecting respiratory capacity in skeletal muscle of obese rats
Daniel A. Kane et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
A Meta-Analysis of Randomized Trials for the Treatment of Nonalcoholic Fatty Liver Disease
Giovanni Musso et al.
HEPATOLOGY (2010)
Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis
Herbert Tilg et al.
HEPATOLOGY (2010)
Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study
G. A. Garinis et al.
INTERNATIONAL JOURNAL OF OBESITY (2010)
Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state
Marc Foretz et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Clarifying metformin's role and risks in liver dysfunction
Carolyn C. Brackett
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION (2010)
Effects of metformin on glucose metabolism of perfused rat livers
Francielli Maria de Souza Silva et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2010)
Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease
Valter Donadon et al.
LIVER INTERNATIONAL (2010)
Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression
Hao Zhang et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis
R. Loomba et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Metformin and Insulin Suppress Hepatic Gluconeogenesis through Phosphorylation of CREB Binding Protein
Ling He et al.
CELL (2009)
Immature Myeloid Cells Induced by a High-Fat Diet Contribute to Liver Inflammation
Zhong-bin Deng et al.
HEPATOLOGY (2009)
Hepatic Autophagy Is Suppressed in the Presence of Insulin Resistance and Hyperinsulinemia INHIBITION OF FoxO1-DEPENDENT EXPRESSION OF KEY AUTOPHAGY GENES BY INSULIN
Hui-Yu Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Metformin Prevents Myocardial Reperfusion Injury by Activating the Adenosine Receptor
Marta Paiva et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2009)
Berberine improves free-fatty-acid-induced insulin resistance in L6 myotubes through inhibiting peroxisome proliferator-activated receptor γ and fatty acid transferase expressions
Yanfeng Chen et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2009)
Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin. receptor expression
Wei-Jia Kong et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2009)
Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial
John Willy Haukeland et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
David M. Nathan et al.
DIABETES CARE (2009)
Berberine improves glucose metabolism through induction of glycolysis
Jun Yin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice
Xu Huang et al.
BIOCHEMICAL JOURNAL (2008)
Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: A mechanism for the action of berberine to activate AMP-Activated protein kinase and improve insulin action
Nigel Turner et al.
DIABETES (2008)
Rosiglitazone no longer recommended
[Anonymous]
LANCET (2008)
Thiazolidinedione insulin sensitizers and the heart: a tale of two organs?
R. E. Buckingham et al.
DIABETES OBESITY & METABOLISM (2008)
Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease
Elisa Fabbrini et al.
GASTROENTEROLOGY (2008)
S6K Directly Phosphorylates IRS-1 on Ser-270 to Promote Insulin Resistance in Response to TNF-α Signaling through IKK2
Jin Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Polymorphism in human organic cation transporters and metformin action
Hiroshi Takane et al.
PHARMACOGENOMICS (2008)
AMPK: a metabolic gauge regulating whole-body energy homeostasis
Ricardo Lage et al.
TRENDS IN MOLECULAR MEDICINE (2008)
Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling
John W. Calvert et al.
DIABETES (2008)
Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis
Chantal A. Rivera et al.
JOURNAL OF HEPATOLOGY (2007)
Activation of 5′-AMP-activated kinase with diabetes drug metformin induces casein kinase Iε (CKIε)-dependent degradation of clock protein mPer2
Jee Hyun Um et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth
Monica Buzzai et al.
CANCER RESEARCH (2007)
Global gene expression analysis in liver of obese diabetic db/db mice treated with metformin
M. Heishi et al.
DIABETOLOGIA (2006)
5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside and metformin inhibit hepatic glucose phosphorylation by an AMP-activated protein kinase-independent effect on glucokinase translocation
B Guigas et al.
DIABETES (2006)
Currently listed contraindications to the use of metformin - more harmful than beneficial?
A Holstein et al.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2006)
Neither LKB1 nor AMPK are the direct targets of metformin
David Grahame Hardie
GASTROENTEROLOGY (2006)
The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin
RJ Shaw et al.
SCIENCE (2005)
A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease
E Bugianesi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
DS Cai et al.
NATURE MEDICINE (2005)
Metformin in the treatment of patients with non-alcoholic steatohepatitis
A Uygun et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Molecular mediators of hepatic steatosis and liver injury
JD Browning et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial
S Nair et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells
MW Zang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus - Systematic review and meta-analysis
SR Salpeter et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Metformin and thiazolidinedione use in medicare patients with heart failure
FA Masoudi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
An intracellular modulation of free radical production could contribute to the beneficial effects of metformin towards oxidative stress
D Bonnefont-Rousselot et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2003)
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome
G Marchesini et al.
HEPATOLOGY (2003)
Metformin-associated lactic acidosis in a patient with liver disease
CMB Edwards et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2003)
Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation
GL Su
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2002)
Hepatotoxicity of commonly used drugs: Nonsteroidal anti-inflammatory drugs, antihypertensives, antidiabetic agents, anticonvulsants, lipid-lowering agents, psychotropic drugs
S Chitturi et al.
SEMINARS IN LIVER DISEASE (2002)
Differentiating members of the thiazolidinedione class: a focus on safety
HE Lebovitz
DIABETES-METABOLISM RESEARCH AND REVIEWS (2002)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Metformin in non-alcoholic steatohepatitis
G Marchesini et al.
LANCET (2001)
The acute effect of metformin on glucose production in the conscious dog is primarily attributable to inhibition of glycogenolysis
CA Chu et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2000)
Effect of four-week metformin treatment on plasma and erythrocyte antioxidative defense enzymes in newly diagnosed obese patients with type 2 diabetes
D Pavlovic et al.
DIABETES OBESITY & METABOLISM (2000)
Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain
MR Owen et al.
BIOCHEMICAL JOURNAL (2000)
Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I
MY El-Mir et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Metformin reverses fatty liver disease in obese, leptin-deficient mice
HZ Lin et al.
NATURE MEDICINE (2000)
Share Paper
